Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.9800
Dollar change
-0.0075
Percentage change
-0.76
%
Index- P/E- EPS (ttm)-1.01 Insider Own66.20% Shs Outstand27.86M Perf Week-4.85%
Market Cap27.30M Forward P/E- EPS next Y-0.41 Insider Trans0.00% Shs Float9.42M Perf Month2.93%
Income-26.78M PEG- EPS next Q-0.15 Inst Own28.71% Short Float0.14% Perf Quarter-24.62%
Sales2.01M P/S13.58 EPS this Y30.69% Inst Trans0.31% Short Ratio0.49 Perf Half Y-52.20%
Book/sh1.39 P/B0.71 EPS next Y41.43% ROA-58.27% Short Interest0.01M Perf Year-77.02%
Cash/sh1.36 P/C0.72 EPS next 5Y- ROE-66.24% 52W Range0.90 - 4.48 Perf YTD-11.31%
Dividend Est.- P/FCF- EPS past 5Y11.01% ROI-67.20% 52W High-78.12% Beta1.34
Dividend TTM- Quick Ratio9.10 Sales past 5Y3540.46% Gross Margin- 52W Low8.89% ATR (14)0.08
Dividend Ex-Date- Current Ratio9.10 EPS Y/Y TTM-55.92% Oper. Margin-1436.43% RSI (14)39.87 Volatility5.36% 7.21%
Employees36 Debt/Eq0.04 Sales Y/Y TTM-48.17% Profit Margin-1331.01% Recom1.00 Target Price7.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q30.59% Payout- Rel Volume0.48 Prev Close0.99
Sales Surprise-118.40% EPS Surprise2.86% Sales Q/Q347.00% EarningsMar 13 BMO Avg Volume27.67K Price0.98
SMA20-7.29% SMA50-14.07% SMA200-48.84% Trades Volume13,415 Change-0.76%
Date Action Analyst Rating Change Price Target Change
Oct-21-22Resumed Jefferies Hold $5.50
Dec-31-19Reiterated JMP Securities Mkt Outperform $20 → $33
Dec-31-19Reiterated H.C. Wainwright Buy $23 → $26
Mar-13-24 07:00AM
Nov-30-23 07:00AM
Nov-28-23 08:06AM
Nov-09-23 07:00AM
Oct-31-23 06:43AM
10:05AM Loading…
Oct-30-23 10:05AM
Aug-30-23 08:00AM
Aug-10-23 08:15AM
07:00AM
Jul-21-23 06:04AM
Jun-06-23 07:30AM
Jun-02-23 06:09AM
May-12-23 08:25AM
07:00AM
Apr-22-23 08:19AM
05:43AM Loading…
Mar-22-23 05:43AM
Mar-20-23 07:00AM
Mar-15-23 11:44AM
Mar-12-23 08:23AM
Mar-10-23 08:15AM
07:00AM
Feb-27-23 06:02AM
Feb-23-23 02:32PM
Jan-27-23 07:29AM
07:00AM
Dec-08-22 06:16AM
Dec-07-22 10:52AM
Nov-10-22 04:00AM
Nov-03-22 03:03PM
Oct-03-22 08:00AM
01:00PM Loading…
Sep-19-22 01:00PM
Sep-12-22 04:30AM
Sep-09-22 12:13PM
Aug-04-22 06:00AM
Jun-01-22 08:00AM
May-27-22 11:45AM
May-17-22 07:00AM
May-13-22 07:00AM
Apr-25-22 07:00AM
Apr-14-22 08:30AM
Apr-12-22 11:26AM
Mar-30-22 07:00AM
Mar-25-22 11:00AM
Dec-22-21 04:05PM
Dec-21-21 07:00AM
Nov-30-21 08:27AM
Nov-11-21 07:00AM
Nov-09-21 07:05AM
Nov-04-21 07:30AM
Oct-01-21 12:14PM
Sep-22-21 07:30AM
Sep-09-21 08:30AM
Aug-17-21 01:30PM
Aug-04-21 07:05AM
Jul-27-21 10:26AM
09:15AM
Jul-20-21 07:05AM
Jun-28-21 05:10AM
05:00AM
May-27-21 07:00AM
May-18-21 09:27AM
May-13-21 07:05AM
Apr-28-21 08:41PM
Apr-27-21 02:20PM
10:02AM
Mar-19-21 06:56AM
Mar-10-21 10:29AM
Mar-04-21 07:05AM
Feb-24-21 07:05AM
Jan-18-21 07:49AM
Jan-11-21 07:05AM
Dec-07-20 07:05AM
Dec-01-20 08:33AM
Nov-18-20 12:08AM
Nov-16-20 01:25AM
Nov-12-20 08:21AM
07:05AM
Nov-09-20 07:05AM
Nov-04-20 04:05PM
Sep-28-20 02:34PM
Sep-10-20 04:01PM
Sep-08-20 07:05AM
Sep-03-20 07:05AM
Aug-06-20 07:08AM
Jul-29-20 07:05AM
Jul-28-20 08:27AM
07:05AM
Jun-29-20 07:00AM
Jun-16-20 04:05PM
Jun-04-20 05:28PM
May-27-20 09:00AM
May-14-20 07:05AM
May-07-20 04:05PM
Apr-13-20 07:05AM
Mar-26-20 07:05AM
Mar-25-20 11:08AM
09:25AM
Mar-24-20 04:05PM
04:00PM
Mar-19-20 05:45PM
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.